Citations

Showing 10 of 108119 citations.

Differences in disease characteristics, treatment patterns, and outcomes between men (M) and women (W) with follicular lymphoma (FL): Prospective evaluation of 2,650 U.S. patients (pts).
Nabhan, Chadi , Byrtek, Michelle, Dawson, Keith, Friedberg, Jonathan W. , Flowers, Christopher R. , Zhou, Xiaolei , Ziemiecki, Ryan , Zelenetz, Andrew D. , Cerhan, James R.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8550-8550

10.1200/jco.2014.32.15_suppl.8550 Get It

Utility of restaging bone marrow biopsy (BMB) in PET-negative patients with diffuse large B-cell lymphoma (DLBCL) with bone marrow involvement.
Jackson, Amie E., Smeltzer, Jacob P., Jones, Jason M. , Burnette, Brian L., Ristow, Kay M., Wiseman, Gregory A., Macon, William R. , Nowakowski, Grzegorz S. , Habermann, Thomas M. , Witzig, Thomas E.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8541-8541

10.1200/jco.2014.32.15_suppl.8541 Get It

Ikaros expression levels to predict response and survival following pomalidomide and dexamethasone in multiple myeloma (MM).
Zhu, Yuan Xiao , Shi, Chang‐Xin, Bruins, Laura A., Schmidt, Jessica, Chang, Xiu-Bao, Moulun, Luo, Jedlowski, Patrick , LaPlant, Betsy, Laumann, Kristina, Lacy, Martha Q. , Champion, Mia D., Stewart, A. Keith, Braggio, Esteban , Kortüm, K. Martin , Chang, Xiu-Bao, Langlais, Paul R. , Moulun, Luo, Fonseca, Rafaël , Bergsagel, P. Leif , Mıkhael, Joseph , Stewart, A. Keith

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8540-8540

10.1200/jco.2014.32.15_suppl.8540 Get It

A phase I trial of SAR650984, a CD38 monoclonal antibody, in relapsed or refractory multiple myeloma.
Martin, Thomas G. , Hsu, Karl , Glenn, Martha, Strickland, Stephen Anthony , Mıkhael, Joseph , Charpentier, Éric

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8532-8532

10.1200/jco.2014.32.15_suppl.8532 Get It

SWOG 1211: A randomized phase I/II study of optimal induction therapy for newly diagnosed high-risk multiple myeloma (HRMM).
Usmani, Saad Zafar, Hoering, Antje , Sexton, Rachel , Shah, Jatin J., Fredette, Sandi, Durie, Brian G.M. , Zonder, Jeffrey A. , Dhodapkar, Madhav V. , Mahindra, Anuj, Zimmerman, Todd M., Richardson, Paul G. , Usmani, Saad Zafar, Ailawadhi, Sikander , Rajkumar, S. Vincent , Richardson, Paul Gerard Guy , Orlowski, Robert Z.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS8624-TPS8624

10.1200/jco.2014.32.15_suppl.tps8624 Get It

Presence and function of CD14+CD16-HLADRlow monocytes in the peripheral blood of patients with Β-cell non-Hodgkin lymphoma (NHL).
Xiu, Bing, Grote, Deanna M., Ziesmer, Steven C., Gustafson, Michael P. , Maas, Mary, Zhang, Zhe , Dietz, Allan B. , Liang, Aibin , Porrata, Luis F. , Novak, Anne J. , Ansell, Stephen M. , Dietz, Allan B , Lin, Yi , Yang, Zhi Zhang

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: e19539-e19539

10.1200/jco.2014.32.15_suppl.e19539 Get It

Effect of lenalidomide combined with R-CHOP (R2CHOP) on negative prognostic impact of nongerminal center (non-GCB) phenotype in newly diagnosed diffuse large B-cell lymphoma: A phase 2 study.
Nowakowski, Grzegorz S. , LaPlant, Betsy, Macon, William R. , Reeder, Craig B. , Foran, James M. , Nelson, Garth D. , Thompson, Carrie A. , Rivera, Candido E., Inwards, David J. , Micallef, Ivana N. , Johnston, Patrick B. , Porrata, Luis F. , Ansell, Stephen M. , Habermann, Thomas M. , Witzig, Thomas E.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8520-8520

10.1200/jco.2014.32.15_suppl.8520 Get It

Efficacy of siltuximab in patients with previously treated multicentric Castleman’s disease (MCD).
Munshi, Nikhil C. , Ke, Xiaoyan , Simpson, David , Lechowicz, Mary Jo , Bandekar, Rajesh, Qin, Xiang , Qi, Ming , Vermeulen, Jessica, Rhee, Frits van , Wong, Raymond , Fosså, Alexander , Dispenzieri, Angela , Kuruvilla, John , Vermeulen, Jessica, Casper, Corey

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8514-8514

10.1200/jco.2014.32.15_suppl.8514 Get It

E1A06: A phase III trial comparing melphalan, prednisone, and thalidomide (MPT) versus melphalan, prednisone, and lenalidomide (MPR) in newly diagnosed multiple myeloma (MM).
Stewart, A. Keith, Jacobus, Susanna , Weiss, Matthias , Chanan‐Khan, Asher , Fonseca, Rafaël , Callander, Natalie S. , Rajkumar, S. Vincent

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8511-8511

10.1200/jco.2014.32.15_suppl.8511 Get It

Tumor heterogeneity revealed by drug-induced apoptosis (MiCK) assays in lung cancer.
Wigle, Dennis A. , Presant, Cary A. , Hallquist, Allan, Perrée, Mathieu, Rutledge, James, Molina, Julian R.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: e19115-e19115

10.1200/jco.2014.32.15_suppl.e19115 Get It